If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
187
Followers on Owler
DiaCarta
develops and commercializes molecular diagnostics products for cancer and infectious diseases...
Read more
Overview
Competitors
Funding
News & Insights
DiaCarta
develops and commercializes molecular diagnostics products for cancer and infectious diseases...
Read more
President & CEO
Aiguo Zhang
CEO Approval Rating
50/100
Weigh In
2010
Pleasanton
California
San Francisco Bay Area
Private
Health Care Equipment & Services
Health Care Technology
8000
NAICS listing
https://www.diacarta.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$55M
News
Latest News
Jan 03, 2025
StreetInsider
Press Release: DiaCarta : DiaCarta Reports Positive Clinical Trial Data For Its Blood Based Test to Triage FIT-Positive Patients Enrolled in CRC Screening Programs
Oct 03, 2024
Benzinga
DiaCarta: DiaCarta Enters Contract with the VA Health Care System (San Francisco) for VEXAS Syndrome Testing
Sep 04, 2024
DiaCarta Blog
DiaCarta Blog DiaCarta Helps Communities Scale Up Their MPOX Testing Efforts with Its Simple, Reliable, and FDA-EUA-Approved MPOX Testing Kits
Jun 27, 2024
DiaCarta Blog
DiaCarta Blog DiaCarta and Capstone Health Alliance Collaborate to Bring Revolutionary Diagnostic Tests to Enhance Patient Care
Jun 26, 2024
Yahoo
DiaCarta: DiaCarta and Capstone Health Alliance Collaborate to Bring Revolutionary Diagnostic Tests to Enhance Patient Care
Apr 08, 2024
DiaCarta Blog
DiaCarta Blog NGS test for colorectal cancer to guide targeted therapy
Apr 04, 2024
DiaCarta Blog
DiaCarta Blog Detection of ROS1, RET, and ALK fusions in non-small cell lung cancer
Mar 11, 2024
DiaCarta Blog
DiaCarta Blog Florida Selects DiaCarta’s cfDNA Test (RadTox™) for Statewide Use to Detect Early Response of Cancer Treatment
Mar 11, 2024
StreetInsider
Press Release: DiaCarta : Florida Selects DiaCarta's cfDNA Test (RadTox ) for Statewide Use to Detect Early Response of Cancer Treatment
Mar 11, 2024
PR Newswire
DiaCarta: Florida Selects DiaCarta's cfDNA Test (RadTox ) for Statewide Use to Detect Early Response of Cancer Treatment
Follow and Get Alerts
DiaCarta Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
Unlock 5 + competitors
Trending Companies